Julie H. Ishida
Gilead Sciences (United States) · 26 works · 1,349 citations · h-index 18
Top works
- Risks and Benefits of Marijuana Use
- International consensus definitions of clinical trial outcomes for kidney failure: 2020
- Smoking, Vaping, and Use of Edibles and Other Forms of Marijuana Among U.S. Adults
- Gabapentin and Pregabalin Use and Association with Adverse Outcomes among Hemodialysis Patients
- Medical Reasons for Marijuana Use, Forms of Use, and Patient Perception of Physician Attitudes Among the US Population
- Opioid Analgesics and Adverse Outcomes among Hemodialysis Patients
- Comparison of Hospitalization Rates among For-Profit and Nonprofit Dialysis Facilities
- Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients
- Sources of Information and Beliefs About the Health Effects of Marijuana
- Iron and Infection in Hemodialysis Patients
- Substitution of marijuana for opioids in a national survey of US adults
- Dialysis Facility Profit Status and Compliance With a Black Box Warning
- Receipt of Intravenous Iron and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection
- Exclusion of Patients With Kidney Disease From Cardiovascular Trials
- Marijuana Use and Estimated Glomerular Filtration Rate in Young Adults
- Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults
- Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes
- Psychoactive Medications and Adverse Outcomes among Older Adults Receiving Hemodialysis
- Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney Disease
- Perceptions of the Comparative Safety of Different Forms of Marijuana Use Among the Adult US Population